Cody J. Peer

7.9k total citations
156 papers, 4.0k citations indexed

About

Cody J. Peer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cody J. Peer has authored 156 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 61 papers in Molecular Biology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cody J. Peer's work include Histone Deacetylase Inhibitors Research (16 papers), Cancer therapeutics and mechanisms (16 papers) and Glioma Diagnosis and Treatment (13 papers). Cody J. Peer is often cited by papers focused on Histone Deacetylase Inhibitors Research (16 papers), Cancer therapeutics and mechanisms (16 papers) and Glioma Diagnosis and Treatment (13 papers). Cody J. Peer collaborates with scholars based in United States, United Kingdom and Israel. Cody J. Peer's co-authors include William D. Figg, Richard Piekarz, Susan E. Bates, Seth M. Steinberg, Robin Frye, Tristan M. Sissung, Elise C. Kohn, Erin R. Gardner, Liang Cao and Jane B. Trepel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Cody J. Peer

154 papers receiving 4.0k citations

Peers

Countries citing papers authored by Cody J. Peer

Since Specialization

Citations

This map shows the geographic impact of Cody J. Peer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cody J. Peer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cody J. Peer more than expected).

Fields of papers citing papers by Cody J. Peer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cody J. Peer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cody J. Peer. The network helps show where Cody J. Peer may publish in the future.

Co-authorship network of co-authors of Cody J. Peer

This figure shows the co-authorship network connecting the top 25 collaborators of Cody J. Peer. A scholar is included among the top collaborators of Cody J. Peer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cody J. Peer. Cody J. Peer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy 2025 ·Arthritis & Rheumatology ·Sara Alehashemi, Bjoern Buehring, Adriana A. de Jesus, (unknown), Andre Rastegar, (unknown), (unknown), Oluwatobi Arisa, William D. Figg, Danielle Fink, Douglas B. Kuhns, (unknown), Cody J. Peer, Raphaela Goldbach‐Mansky	4
2	Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers 2024 ·Frontiers in Oncology ·(unknown), Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, (unknown), Min-Jung Lee, Shraddha Rastogi, N Sato, Yunkai Yu, (unknown), Seth M. Steinberg, (unknown), Liang Cao, William D. Figg, Jane B. Trepel, Ira Pastan, David FitzGerald, Christine Alewine	3
3	Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease 2024 ·SHILAP Revista de lepidopterología ·Taylor McManus, Noa G. Holtzman, (unknown), (unknown), Susan Vitale, Edmond J. FitzGibbon, Debbie Payne, (unknown), (unknown), Annie Im, Cody J. Peer, William D. Figg, Edward W. Cowen, Jacqueline W. Mays, Steven Z. Pavletic, M. Teresa Magone	1
4	Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047) 2023 ·Neuro-Oncology ·Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan Robison, Lindsay Kilburn, Anna Vinitsky, William D. Figg, Nada Jabado, Maryam Fouladi, Jason Fangusaro, Arzu Onar‐Thomas, Ira J. Dunkel, (unknown)	31
5	In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation 2023 ·The Journal of Clinical Pharmacology ·Cody J. Peer, Keith T. Schmidt, Oluwatobi Arisa, (unknown), (unknown), Daniel A. Goldstein, James L. Gulley, William D. Figg, Mark J. Ratain	9
6	Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics 2021 ·Science Translational Medicine ·Jay‐Hyun Jo, Catriona P. Harkins, (unknown), (unknown), (unknown), Matthew Zimmerman, Claire L. Carter, (unknown), Cody J. Peer, Eric C. Polley, Véronique Dartois, William D. Figg, Niki M. Moutsopoulos, Julia A. Segre, Heidi H. Kong	71
7	A Very Long-Acting PARP Inhibitor Suppresses Cancer Cell Growth in DNA Repair-Deficient Tumor Models 2020 ·Cancer Research ·Shaun D. Fontaine, Gary W. Ashley, Peter J. Houghton, Raushan T. Kurmasheva, Morgan E. Diolaiti, Alan Ashworth, Cody J. Peer, (unknown), William D. Figg, Denis Beckford-Vera, Daniel V. Santi	16
8	Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures 2020 ·Molecular Cancer Research ·Christina R. Ross, Karol Szczepanek, Maxwell Lee, Howard H. Yang, Cody J. Peer, (unknown), (unknown), Zhi-Wei Lin, (unknown), William D. Figg, Kent W. Hunter	14
9	Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma 2020 ·Molecular Cancer Therapeutics ·Bih‐Rong Wei, Shelley Hoover, Cody J. Peer, Jennifer E. Dwyer, Hibret A. Adissu, (unknown), Howard H. Yang, Maxwell Lee, (unknown), William D. Figg, R. Mark Simpson	15
10	IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion 2019 ·Clinical Cancer Research ·Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi‐Chia Richard Lee, Miloš D. Miljković, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer L. Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann	95
11	Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma 2019 ·Clinical Cancer Research ·Christine Alewine, (unknown), Cody J. Peer, Zishuo I. Hu, Min-Jung Lee, Akira Yuno, (unknown), Anish Thomas, Seth M. Steinberg, Jane B. Trepel, William D. Figg, Raffit Hassan, Ira Pastan	40
12	Local and Systemic Antitumor Effects of Photo‐activatable Paclitaxel Prodrug on Rat Breast Tumor Models 2019 ·Photochemistry and Photobiology ·Subramaniyan Bharathiraja, Pallavi Rajaputra, (unknown), Mengjie Li, Cody J. Peer, (unknown), William D. Figg, Sukyung Woo, Youngjae You	3
13	Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors 2018 ·Molecular Cancer Therapeutics ·Laetitia Marzi, Keli Agama, Junko Murai, Simone Difilippantonio, (unknown), Cody J. Peer, William D. Figg, (unknown), Mohamed Elsayed, Mark Cushman, Yves Pommier	32
14	Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma 2017 ·Clinical Cancer Research ·Austin G. Duffy, Chi Ma, Susanna V. Ulahannan, Osama E. Rahma, Oxana V. Makarova‐Rusher, Liang Cao, Yunkai Yu, David E. Kleiner, Jane B. Trepel, Min-Jung Lee, Yusuke Tomita, Seth M. Steinberg, Theo Heller, Barış Türkbey, Peter L. Choyke, Cody J. Peer, William D. Figg, Bradford J. Wood, Tim F. Greten	68
15	Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study 2016 ·Journal of Clinical Oncology ·Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, Karen Aleman, Cody J. Peer, Margaret Bevans, Irini Sereti, Frank Maldarelli, Denise Whitby, Vickie Marshall, Priscila Gonçalves, Vikram Khetani, William D. Figg, Seth M. Steinberg, Jerome B. Zeldis, Robert Yarchoan	86
16	Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer 2016 ·Clinical Cancer Research ·Jung Min Lee, Cody J. Peer, Minshu Yu, Lauren Amable, Nicolas Gordon, Christina M. Annunziata, Nicole Houston, Andrew K.L. Goey, Tristan M. Sissung, (unknown), Lori M. Minasian, Victoria L. Chiou, Robert F. Murphy, Brigitte C. Widemann, William D. Figg, Elise C. Kohn	47
17	Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells 2015 ·Clinical Cancer Research ·Mahadev Rao, (unknown), Vivek Shukla, Young Ki Hong, Trevor Upham, R. Taylor Ripley, Julie A. Hong, Mary Zhang, (unknown), Patricia Fetsch, Markku Miettinen, Xinmin Li, Cody J. Peer, Tristan M. Sissung, William D. Figg, Assunta De Rienzo, Raphael Bueno, David S. Schrump	25
18	Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues 2015 ·Molecular Cancer Therapeutics ·Shaunna Beedie, Cody J. Peer, (unknown), Erin R. Gardner, (unknown), S. Barnett, (unknown), Michael Gütschow, Cindy H. Chau, Neil Vargesson, William D. Figg	27
19	A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study 2014 ·Clinical Cancer Research ·Anish Thomas, Arun Rajan, Éva Szabó, Yusuke Tomita, Corey A. Carter, Barbara Scepura, Ariel López-Chávez, Min-Jung Lee, Christophe E. Redon, (unknown), Cody J. Peer, Yuanbin Chen, Richard Piekarz, Seth M. Steinberg, Jane B. Trepel, William D. Figg, David S. Schrump, Giuseppe Giaccone	79
20	Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers 2013 ·Clinical Cancer Research ·Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer, Kambiz Ghafourian, James C. Reynolds, (unknown), Robin Frye, (unknown), David Venzon, John J. Wright, Monica C. Skarulis, William D. Figg, Tito Fojo, Susan E. Bates, Richard Piekarz	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact